Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

AgelessRx Tirzepatide Review: Cost, Brand Access & Honest Verdict (2026)

An honest 2026 review of AgelessRx tirzepatide — an established longevity brand, brand-name access, and thin GLP-1-specific detail.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Trimi

One of the lowest compounded rates here — but only if you prepay a year up front.

$125/mo (annual prepay) · $235 monthly

Check Trimi availability

AgelessRx is an Ann Arbor, Michigan-based longevity and GLP-1 telehealth platform, offering compounded semaglutide, compounded tirzepatide, and brand-name Wegovy. It's a more established brand than many single-purpose GLP-1 startups, with longevity-first positioning that frames metabolic health more broadly than a single-condition funnel. Every fact here comes from the company's own published program.

What AgelessRx is

AgelessRx is a genuinely separate company from **Ageless (tryageless.com), a similarly-named but unrelated provider also reviewed on this site — worth double-checking you've landed on the right one before you pay. AgelessRx is based in Ann Arbor, Michigan, offering compounded semaglutide, compounded tirzepatide, and brand-name Wegovy through U.S.-licensed providers. Its longevity-first positioning**, gives it a broader metabolic-health framing than the single-condition GLP-1 funnels many competitors run.

§ AgelessRx — What's Confirmed vs. Unconfirmed

ClaimStatus
Location & framingVerified
Brand Wegovy accessVerified
$159 microdose tierVerified
Full price ladder, states servedNot independently confirmed
Verified: location, longevity framing, brand Wegovy access, and a $159 microdose tier. Unconfirmed: full pricing ladder, states served, GLP-1 intake workflow.

What AgelessRx costs

AgelessRx advertises a $159/month microdose tier — a starting-dose figure for a specific microdosing protocol rather than a standard therapeutic dose. This review could not independently confirm the full price ladder for a standard therapeutic tirzepatide dose, the specific states served, or the exact GLP-1 intake workflow — confirm these directly with AgelessRx before assuming the microdose figure applies to your situation.

The brand-vs-compounded question

Two very different products share the name tirzepatide:

  • Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
  • Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

AgelessRx offers both compounded tirzepatide and brand-name Wegovy (semaglutide) — though its confirmed brand pathway is for the semaglutide product specifically, not a brand tirzepatide option. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

AgelessRx's real strengths: an established brand with US-licensed providers, both compounded and brand-name options on the semaglutide side, a longevity-first framing that broadens the metabolic-health picture beyond one drug, and presence across multiple competitor directories. The trade-offs: this review could not confirm the full pricing ladder beyond the $159 microdose tier, states served, or the complete GLP-1 intake workflow — and because GLP-1 is one of several products on a longevity-first platform, you may be funneled into a broader intake than a single-purpose weight-loss provider would run. As with any GLP-1 program, get the standard-dose price and your state's availability confirmed directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

AgelessRx is a more established platform than many single-purpose GLP-1 startups, but this review couldn't independently confirm its full tirzepatide pricing beyond a $159 microdose tier — get the standard-dose price and state coverage in writing before you commit. If you want a provider whose pricing this review confirmed more fully, compare it against ShedRx or CoreAge Rx. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through AgelessRx?

AgelessRx advertises a $159/month microdose tier — a starting-dose figure for a specific protocol. This review could not independently confirm the full pricing ladder for a standard therapeutic dose; confirm directly with AgelessRx.

Does AgelessRx offer brand-name medication?

Yes — brand-name Wegovy (semaglutide) is offered alongside compounded tirzepatide, though the confirmed brand pathway is specifically for semaglutide, not tirzepatide.

Is AgelessRx GLP-1-only?

No — AgelessRx is a longevity-first platform, meaning GLP-1 is one of several products rather than the sole focus, which may mean a broader intake than a single-purpose weight-loss provider would run.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.